[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Patient Information Sheet
Bevacizumab (marketed as Avastin)

PDF Print Version PDF document

This is a summary of the most important information about Avastin. For details, talk to your healthcare professional.

What is Avastin used for? 

Avastin is used in combination with:

  • intravenous 5-FU based combination chemotherapy regimens as the first-treatment or second-treatment for patients with metastatic colon cancer (cancer of the colon or rectum that has spread to other areas of the body). 
  • carboplatin and paclitaxel for first‑treatment of patients with unresectable (unable to remove by operation), locally advanced, recurrent or metastatic non-squamous, non-small cell lung cancer.

Avastin will not cure colorectal cancer or lung cancer.  Overall, patients given Avastin plus chemotherapy for treatment of either colon cancer or lung cancer that has spread live longer than those who receive only chemotherapy. 

Special Warning(s) with Avastin:    

  • Avastin may cause gastrointestinal perforation (holes in the stomach, intestines or colon) requiring surgery to repair.
  • Avastin may impair wound healing or cause wounds to open up.  Avastin should not be started for at least 28 days following major surgery and full wound healing, and should be stopped before a scheduled surgery.  
  • Mild bleeding (such as nosebleeds) is common in patients who receive Avastin.  Serious bleeding from the lungs or digestive system, requiring blood transfusions, occur in less than 5% of patients receiving Avastin.  When very severe, patients have died from blood loss.
  • Avastin may cause a severe increase in blood pressure so patients receiving Avastin should have their blood pressure checked regularly.
  • Avastin may cause proteinuria (protein in the urine, a sign of kidney damage).
  • Avastin may cause blood clots.  The chances of blood clots are highest in patients who are elderly.
  • Avastin may cause congestive heart failure (failure of the heart to pump blood well) especially when given with chemotherapy that is known to damage the heart (such as doxorubicin).

General Precautions with Avastin:

  • Avastin should be used with caution in patients who are allergic to Avastin or to any of the ingredients in Avastin.
  • Avastin may cause severe infusion reactions such as trouble breathing. This usually happens during the first dose, so patients should receive treatment in a doctor’s office or clinic.

What should I tell my healthcare provider?

Tell your healthcare provider if you:

  • have or had liver or kidney problems
  • have high blood pressure
  • have congestive heart failure or other heart problems
  • are pregnant, are trying to become pregnant, or are breast-feeding
  • have recently had surgery or are planning to have surgery

Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.  Some medicines may affect how Avastin works or Avastin may affect how your other medicines work.

What are some possible side effects of Avastin? (This list is NOT a complete list of side effects reported with Avastin.  Your healthcare provider can discuss with you a more complete list of side effects.) 

Serious side effects include of Avastin treatment include:

  • gastrointestinal perforation
  • impaired wound healing
  • severe bleeding
  • a dangerously high increase in blood pressure
  • kidney damage
  • blood clots
  • congestive heart failure

More common side effects of Avastin treatment include:

  • tiredness and weakness
  • stomach pain
  • headache
  • high blood pressure
  • diarrhea
  • nausea and vomiting
  • loss of appetite
  • mouth sores
  • constipation
  • lung infections
  • nose bleeds
  • shortness of breath
  • decreased white blood cells
  • skin peeling
  • protein in the urine

For more detailed information about Avastin (bevacizumab), ask your healthcare provider.

 Link to Avastin's Approved Labeling PDF document

Back to Top     Back to Drug Index

PDF document PDF requires the free Adobe Acrobat Reader

Date created: July 21, 2004; Updated: February 1 , 2007